Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Drug-resistant TB

WHO issues critical new TB treatment recommendations and MSF calls on governments to urgently scale-up all oral treatment

Press Release 28 Dec 2018
 
Drug-resistant TB

MSF Calls on US pharma corporation Johnson & Johnson to cut key TB drug price in half

Press Release 22 Oct 2018
 
Briefing Document

DR-TB Drugs Under The Microscope

22 Oct 2018
Briefing Document
 
Drug-resistant TB

MSF response to first-ever UN tuberculosis summit

Press Release 27 Sep 2018
 
Drug-resistant TB

MSF in South Africa calls on SA Government to continue providing global leadership on TB issues

Press Release 26 Sep 2018
 
Drug-resistant TB

Global leaders must make bold commitments at first-ever UN Tuberculosis Summit

Press Release 25 Sep 2018